20 articles
German researchers tested whether 4g daily taurine could slow aging processes in adults 55-75 over 6 months of supplementation.
New research reveals how a specific protein helps parathyroid hormone accelerate bone repair, offering insights for fracture treatment.
New delivery method improves calcium control and quality of life in patients with treatment-resistant hypoparathyroidism.
Researchers discover atovaquone enhances cancer drug effectiveness by targeting cellular energy production in aggressive breast tumors.
Researchers identify PANoptosis as a key mechanism in Alzheimer's, opening doors to novel therapeutic approaches.
Even after 4+ years in remission, Cushing's disease patients retain abnormal plasma protein profiles linked to coagulation and cardiovascular risk.
Scientists identify how CTPS1 enzyme drives lymphoma progression through cellular recycling pathways, opening new treatment possibilities.
Teprotumumab successfully treated severe pretibial dermopathy in five patients, offering hope for this disfiguring autoimmune skin condition.
New research reveals how a key brain protein regulates stress hormones, body temperature, and fat storage in adults.
New research reveals how GDF-11 regulates placental development and may explain preeclampsia risk through trophoblast cell invasion mechanisms.
30-day PQQ supplementation significantly lowered inflammatory markers and cholesterol in Western diet-fed baboons without weight loss.
Adult-onset pseudohypoparathyroidism went undiagnosed until specialized genetic testing revealed the true cause of mysterious symptoms.
New research reveals how the mitochondrial protein Lonp1 protects brain cells from aging-related damage and cognitive decline.
Study of 33 men finds testosterone replacement therapy improved symptoms with low cancer recurrence rates in prostate cancer survivors.
Phase II trial tests testosterone replacement in 136 prostate cancer survivors to combat androgen deficiency symptoms.
A GLP-1 receptor-targeted PET/CT scan located insulin-secreting tumors in nearly three-quarters of patients where conventional imaging had failed.
Daily hydrogen inhalation reduced brain inflammation and amyloid plaques in Alzheimer's disease mice over just 4 weeks.
New meta-analysis reveals thyroid cancer recurrence progresses in 23-70% of patients under active surveillance, challenging current practices.
A new clinical review maps both established and emerging germline genes behind pituitary adenomas, reshaping how clinicians screen and counsel patients.
New hypothesis reveals how brain cells may detoxify harmful compounds that contribute to Parkinson's disease progression.
